Sanofi Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include AstraZeneca, Lilly and AbbVie.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | |
Founding Date | Founding Date 2020 | Founding Date 1999 | Founding Date 1876 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more |
Employees | Employees 38,0003% increase | Employees 94,300 | Employees 47,0009% increase | Employees 55,00010% increase |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 2.7 b | Valuation ($) 903.4 b | Valuation ($) 335 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) | Revenue (est.) $61.2b (FY, 2025) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods $11.1b (FY, 2025) | Cost of goods $18.2b (FY, 2025) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit $54.1b (FY, 2025) | Gross profit $43b (FY, 2025) |
Net income | Net income ($3.5b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income $20.6b (FY, 2025) | Net income $4.2b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 165 (Q1, 2023) | Countries 130 (FY, 2021) | Countries 120 (FY, 2021) | Countries 70 (FY, 2022) |
Product Categories | Product Categories 3 (Q1, 2023) | Product Categories N/A | Product Categories N/A | Product Categories 6 (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1b | Total funding raised N/A | Total funding raised $ 3.8b |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View companyAbbVie
HQ
North Chicago, US
Employees
55,000↑ 10% increase
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View company